BTG Pactual Global Asset Management’s Charles River Laboratories CRL Stock Holding History

BTG Pactual Global Asset Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-8,300	Closed	-$527K	–	45
2015 Q3	$527K	Sell	8,300 -1,000	-11%	-$71.8K	0.04%	140
2015 Q2	$654K	Buy	+9,300	New	+$688K	0.04%	124
2014 Q3	–	Sell	-8,271	Closed	-$443K	–	228
2014 Q2	$443K	Buy	+8,271	New	+$454K	0.06%	170

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BTG Pactual Global Asset Management's CRL Position: Q4 2015 in Review

BTG Pactual Global Asset Management sold out of Charles River Laboratories (CRL) in Q4 2015, closing a stake of 8,300 shares — an estimated $527K sold.

BTG Pactual Global Asset Management first reported a position in CRL in Q2 2014 and held it in 3 quarters. The position peaked at $654K in Q2 2015. 268 funds tracked by Wall St. Rank hold CRL as of Q4 2015.

BTG Pactual Global Asset Management reported no remaining Charles River Laboratories position as of Q4 2015 after selling out during the quarter.
BTG Pactual Global Asset Management sold 8,300 Charles River Laboratories shares in Q4 2015, an estimated $527K.
BTG Pactual Global Asset Management first reported a position in Charles River Laboratories in Q2 2014 and held it in 3 quarters.
BTG Pactual Global Asset Management's Charles River Laboratories position peaked at $654K in Q2 2015.
268 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.